[Infections of the Proximal and Distal Interphalangeal Joint: 4 weeks of Immobilisation between initial Surgery with Joint Resection and secondary Joint Fusion is sufficient].

Background: In 2011 we published our treatment regime for infections of the interphalangeal joints of the hand with infection-related macroscopic cartilage damage. We recommended the resection of the infected joint followed by 6 weeks of immobilisation by external fixation before secondary arthrodesis. In 2013 we reduced the period of immobilisation to 4 weeks within a prospective study.

[Treatment of fingertip defect injuries with a semiocclusive dressing according to Mennen and Wiese].

Objective: The goal of conservative treatment of fingertip defects is to restore a stable and bulky pulp with recovery of sensitivity and a good skin quality.

Indications: Traumatic defects of the fingertip with or without involvement of the fingernail and/or exposed distal phalanx.

Contraindications: Fractures of the distal phalanx with dislocation or joint involvement, necessitating an osteosynthesis.

[Treatment of bacterial infection in the interphalangeal joints of the hand].

Objective: Radical debridement of joint infection, prevention of further infection-related tissue destruction.

Indications: Septic arthritis of interphalangeal joints in the thumb and fingers.

Contraindications: Extensive soft tissue defects.

[Intramedullary nail removal in the upper and lower limbs. Should we recommend this operation?].

Background: Absolute indications for removing intramedullary locking nails (ILN) are undisputed, but there are also relative indications when implant removal might be discussed. The aim of our study was to evaluate complications of ILN removal in the upper and lower extremities.

Methods: Four hundred sixty (460) patients who underwent interlocking nail removal were reviewed regarding complications after removal of implants in the humerus, femur, or tibia.

[Technical defects of tourniquet manometers].

The use of a tourniquet causes in 0.013% to 1.15% complications (e.